| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/28/2001 | EP1077725A2 Topical pharmaceutical compositions useful for treating cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis, comprising pollen extract and vegetable oil unsaponifiables |
| 02/28/2001 | EP1077724A2 Methods and products related to metabolic interactions in disease |
| 02/28/2001 | EP1077723A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 02/28/2001 | EP1077721A1 Prevention and treatment of hypergastrinemia |
| 02/28/2001 | EP1077719A1 Vaccine delivery system |
| 02/28/2001 | EP1077718A1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 02/28/2001 | EP1077717A2 Use of lipopeptides or lipoproteins for wound treatment |
| 02/28/2001 | EP1077716A1 Method for the treatment of gastroesophageal reflux disease |
| 02/28/2001 | EP1077708A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 02/28/2001 | EP1077678A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 02/28/2001 | EP1077676A2 Cyclosporin preparations |
| 02/28/2001 | EP0799027B1 Liposomal interferon hybrid compositions |
| 02/28/2001 | EP0769902A4 Methods for reducing hyperacute rejection of xenografts |
| 02/28/2001 | EP0695192B1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0594710B1 Tyrosine kinase |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
| 02/28/2001 | CN1285754A Monoclonal human matural antibodies |
| 02/28/2001 | CN1285747A Combination therapy for treating AIDS |
| 02/28/2001 | CN1285744A Use of histamine for elevating blood histamine levels |
| 02/28/2001 | CN1285409A Blue-green alga shuttle plasmid expression vector and method for expressing thymison 'alpha' 1 |
| 02/28/2001 | CN1285408A Blue-green alga transgene by using gene integration platform system and method for expressing thymosin 'alpha'1 |
| 02/28/2001 | CN1285407A Heat shock induction exogenous gene high-efficient expressed blue-green alga transgenic expression system and the method for expressing thymosin 'alpha'1 |
| 02/28/2001 | CN1285356A Depeptide compound, its medical salt or ester, the medicinal composition using same as active component and the application for treating and preventing cell from dying |
| 02/28/2001 | CN1062565C Recombinating haman alpha type composite interferon and preparation process and use thereof |
| 02/27/2001 | US6194578 Growth hormone secretagogues; useful for prophylaxis and therapy of osteoporosis and/or frailty, insulin resistance in mammals, congestive heart failure, obesity, accelerating bone fracture repair reducing cachexia and protein loss |
| 02/27/2001 | US6194561 Oligonucleotide probes of defined nucleotide sequences which are complementary to second exon of class ii hla beta chain gene; diagnosis of susceptibility to insulin-dependent diabetes mellitus and pemphigus vulgaris; antidiabetic agents |
| 02/27/2001 | US6194558 DNA encoding human monocyte-macrophage apolipoprotein B receptor gene and protein |
| 02/27/2001 | US6194557 Nucleic acid molecules encoding Bap-1 proteins |
| 02/27/2001 | US6194555 Nucleotide sequence encoding a steroidogenic acute regulatory protein; probes; primers; diagnosis and therapy of hormone-dependent disorders like lipoid congenital adrenal hyperplasia |
| 02/27/2001 | US6194549 Partially purified preparation of pen5, a glycoprotein pair; for detecting and/or removing natural killer cells from a mixed population of cells |
| 02/27/2001 | US6194547 ETS2 repressor factor (ERF) |
| 02/27/2001 | US6194544 Cyclic semi-random peptide libraries |
| 02/27/2001 | US6194543 Dendritic polypeptides |
| 02/27/2001 | US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions |
| 02/27/2001 | US6194457 Liquid eye drop composition |
| 02/27/2001 | US6194430 Viral treatment |
| 02/27/2001 | US6194429 Purification with a hydrophobic resin |
| 02/27/2001 | US6194409 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/27/2001 | US6194402 Administering a compound to stimulate the effects of somatotropins to patients after acute deconditioning such as that which may result from immobilization, surgery, or major injury, e.g., hip fracture; |
| 02/27/2001 | US6194401 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid |
| 02/27/2001 | US6194392 Administering to a patient suffering from swelling associated with brain tumours involving tissue of the group consisting of underperfused tissue and pathological tissue an antiswelling agent and a hyaluronic acid to aid penetration |
| 02/27/2001 | US6194386 Labelled peptide compounds |
| 02/27/2001 | US6194385 Calcium-binding protein |
| 02/27/2001 | US6194384 Long-acting galenical formulation for GRF peptides |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/27/2001 | US6194381 Therapeutic agent and method for feline AIDS virus infections and feline atopic dermatitis |
| 02/27/2001 | US6194380 Agents for promoting bone formation |
| 02/27/2001 | US6194378 Fibronectin peptides-based extracellular matrix for wound healing |
| 02/27/2001 | US6194377 Methods for treating nervous system pathophysiologies using glial growth factors |
| 02/27/2001 | US6194376 Method for modulating inflammatory response comprising administering morphogen |
| 02/27/2001 | US6194208 Modified milk growth factor |
| 02/27/2001 | US6194207 Methods for the selective expansion of lymphocytes by in vitro cultivation |
| 02/27/2001 | US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length |
| 02/27/2001 | US6194195 Pure culture; for production of hypotensive agents and therapies for asthma, cerebral apoplexy, angina pectoris, acute renal failure, cardiac infarction, and cerebral vasospasm |
| 02/27/2001 | US6194191 Method for the production and purification of adenoviral vectors |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194177 DNA encoding a hybrid heterodimeric protein |
| 02/27/2001 | US6194176 Recombinant expression of proteins from secretory cell lines |
| 02/27/2001 | US6194175 Nucleotide sequences coding suppressor of transcriptional activity; for treating adult respiratory distress syndrome, allograft rejection, asthma, arthritis, cancer and restenosis; anticarcinogenic agents |
| 02/27/2001 | US6194174 Histidine kinase, 636 HK, of staphylococcus aureus |
| 02/27/2001 | US6194173 Binding proteins for phosphoinositides, GRP1 or general receptor 1 for phophoinositide |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194169 Enhanced expression of human platelet-derived growth factor in Pichia pastoris |
| 02/27/2001 | US6194166 Isolated dna; genetic engineering |
| 02/27/2001 | US6194156 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
| 02/27/2001 | US6194140 HCV NS3 protein fragments having helicase activity and improved solubility |
| 02/27/2001 | US6193997 Proteinic drug delivery system using membrane mimetics |
| 02/27/2001 | US6193983 Equine herpesvirus glycoproteins |
| 02/27/2001 | US6193982 Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193979 Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands |
| 02/27/2001 | US6193972 Hybrid heterodimeric protein hormone |
| 02/27/2001 | US6193971 Dictyocaulus viviparus antigen for diagnosing lungworm infestation and for vaccination |
| 02/27/2001 | US6193970 Potentiating local inflammatory or immune response to administration of tumor antigen in mammalian subject by administering tumor antigen in form of tumor cells, or subcellular antigenic material and cytokine or cytokines |
| 02/27/2001 | US6193969 Preventing, ameliorating, or treating septic shock or its symptoms by administering igg (immunoglobulin g) fab fragments reactive towards tnf.alpha.(tumor nercosis factor), wherein igg fab fragments are derived from polyclonal igg |
| 02/27/2001 | US6193968 Methods for using anti-αvβ3 integrin antibody |
| 02/27/2001 | US6193967 Administering bispecific molecule, comprising: binding specificity for human high density lipoprotein (hdl), or fragment and for an fc.gamma. receptor for immunoglobulin g for treating and prophylaxis of atherosclerosis |
| 02/27/2001 | US6193966 Administering bispecific protein or peptide molecule, comprising a first binding determinate which binds to fc.alpha.receptor without being blocked by immunoglobulin a and second binding determinant which binds to target antigen |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193963 Method of treating tumor-bearing patients with human plasma hyaluronidase |
| 02/27/2001 | US6193948 Contacting sample with purified hu antigenic polypeptide to form complex between purified hu antigenic polypeptide and antibody, detecting presence of complex formed to detect antibody associated with paraneoplastic sensory neuronopathy |
| 02/27/2001 | US6193595 Methods and apparatus for performing processing operations on a slaughtered animal or part thereof |
| 02/27/2001 | CA2232789C Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/27/2001 | CA2194370C Attenuation of wound healing processes |
| 02/27/2001 | CA2189526C Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 02/27/2001 | CA2110582C Modified sialyl lewis a compounds |
| 02/27/2001 | CA2104681C Mineralized collagen |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/27/2001 | CA2096654C Removal of antibodies from blood-derived compositions while retaining coagulation factors |
| 02/27/2001 | CA2066031C Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 02/27/2001 | CA2022177C Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/26/2001 | CA2281010A1 Diagnostic method |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001013113A1 Methods and compositions for modulating somatolactogenic functions |
| 02/22/2001 | WO2001013112A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |